Ramipril-associated lichen planus pemphi
β
G.S. OGG; B.S. BHOGAL; T. HASHIMOTO; R. COLEMAN; J.N.W.N. BARKER
π
Article
π
1997
π
John Wiley and Sons
π
English
β 790 KB
We report the first case of lichen planus pemphigoides (LPP) secondary to ingestion of ramipril, an angiotensin-converting enzyme inhibitor. Clinical, histological and immunofluorescent findings were all consistent with a diagnosis of LPP. Linear basement membrane zone (BMZ) staining with IgG and C3